mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |